BBB National Programs Newsroom

NAD Recommends L’Oréal Discontinue “#1 Dermatologist Recommended” Claim for CeraVe; Advertiser to Appeal

For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs

703.247.9330 / press@bbbnp.org

New York, NY – January 28, 2021 – The National Advertising Division (NAD) of BBB National Programs recommended that L’Oréal USA, Inc. discontinue claims that CeraVe is the “#1 dermatologist recommended skincare brand” and that it is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

The claims at issue, which appeared in online advertising, social media, and on in-store materials for CeraVe skincare products, were challenged by Johnson & Johnson Consumer Inc., the maker of competing Neutrogena brand facial and body cleansers, moisturizers, and sunscreens.

In support of its claim that CeraVe is the “#1 dermatologist recommended skincare brand,” L’Oréal relied on data from an online survey of approximately 1,500 dermatologists, which recorded the number and percentage of dermatologists’ average weekly recommendations by brand name in the surveyed categories. For certain conditions like acne, the survey asks about brand recommendations in multiple product categories, for example, “Acne: Cleansers” and “Acne: Moisturizers/Treatments.” Certain survey categories are identified by particular skin conditions like “Eczema.” Other survey categories call for brand recommendations in a particular product category, which in some instances is tied directly to a specific condition (e.g., “Wart Remover”) and in other instances is not directly tied to a particular condition (e.g., “Male Oriented Skin Care Products”).

L’Oréal relied on the results from 33 of the 48 categories in the survey, which it considered relevant to consumers’ understanding of “skincare,” and omitted those for which dermatologists did not report any recommendations in the 12 months ending December 2019, March 2020, or May 2020, and those it deemed irrelevant to the common conception of “skincare.”

After evaluating the methodology of the survey, although NAD did not take issue with its general methodology or with the particular categories surveyed, NAD determined that it was not reliable because it did not adequately instruct respondents not to duplicate their total average weekly recommendations between and among categories and, therefore, created the possibility of double-counting or that dermatologists would record the same brand recommendation in different categories if the recommendation for a particular indication is applicable in multiple categories. 

NAD further concluded that in the absence of more explicit instructions, the potential for double counting is increased due to the format of the survey and its degree of inherent imprecision. For these reasons, NAD recommended that L’Oréal discontinue the claim that CeraVe is the “#1 dermatologist recommended skincare brand.”

NAD also recommended that L’Oréal discontinue the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

NAD noted that while L’Oréal’s use of the term “non-OTC” is an effort to accurately distinguish its products from acne drug products sold without a prescription, the claim is based on survey data which called for dermatologists’ Average Weekly Recommendations for “OTC” Acne Moisturizer/Treatments and not “Non-OTC” products. NAD determined that “Non-OTC” may also be understood by consumers as a reference to prescription drug products instead of cosmetic products like CeraVe’s. Without a more accurate descriptor such as “non-prescription,” NAD concluded that there was a poor fit between the substantiation and the claim as it appears.

Nothing in NAD’s decision precludes L’Oréal from making truthful and non-misleading claims about dermatologists’ recommendations for its skincare products based on reliable survey data.

In its advertiser’s statement, L’Oréal stated that it will “appeal NAD’s decision that the underlying survey was not sufficiently reliable to support a ‘#1 Dermatologist Recommended Skincare Brand’ claim for the CeraVe brand without revised instructions.” L’Oréal further stated that it “will take NAD’s recommendations into account for future advertising” regarding the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.”

###

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.    

NAD Recommends L’Oréal Discontinue “#1 Dermatologist Recommended” Claim for CeraVe; Advertiser to Appeal

For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs

703.247.9330 / press@bbbnp.org

New York, NY – January 28, 2021 – The National Advertising Division (NAD) of BBB National Programs recommended that L’Oréal USA, Inc. discontinue claims that CeraVe is the “#1 dermatologist recommended skincare brand” and that it is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

The claims at issue, which appeared in online advertising, social media, and on in-store materials for CeraVe skincare products, were challenged by Johnson & Johnson Consumer Inc., the maker of competing Neutrogena brand facial and body cleansers, moisturizers, and sunscreens.

In support of its claim that CeraVe is the “#1 dermatologist recommended skincare brand,” L’Oréal relied on data from an online survey of approximately 1,500 dermatologists, which recorded the number and percentage of dermatologists’ average weekly recommendations by brand name in the surveyed categories. For certain conditions like acne, the survey asks about brand recommendations in multiple product categories, for example, “Acne: Cleansers” and “Acne: Moisturizers/Treatments.” Certain survey categories are identified by particular skin conditions like “Eczema.” Other survey categories call for brand recommendations in a particular product category, which in some instances is tied directly to a specific condition (e.g., “Wart Remover”) and in other instances is not directly tied to a particular condition (e.g., “Male Oriented Skin Care Products”).

L’Oréal relied on the results from 33 of the 48 categories in the survey, which it considered relevant to consumers’ understanding of “skincare,” and omitted those for which dermatologists did not report any recommendations in the 12 months ending December 2019, March 2020, or May 2020, and those it deemed irrelevant to the common conception of “skincare.”

After evaluating the methodology of the survey, although NAD did not take issue with its general methodology or with the particular categories surveyed, NAD determined that it was not reliable because it did not adequately instruct respondents not to duplicate their total average weekly recommendations between and among categories and, therefore, created the possibility of double-counting or that dermatologists would record the same brand recommendation in different categories if the recommendation for a particular indication is applicable in multiple categories. 

NAD further concluded that in the absence of more explicit instructions, the potential for double counting is increased due to the format of the survey and its degree of inherent imprecision. For these reasons, NAD recommended that L’Oréal discontinue the claim that CeraVe is the “#1 dermatologist recommended skincare brand.”

NAD also recommended that L’Oréal discontinue the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

NAD noted that while L’Oréal’s use of the term “non-OTC” is an effort to accurately distinguish its products from acne drug products sold without a prescription, the claim is based on survey data which called for dermatologists’ Average Weekly Recommendations for “OTC” Acne Moisturizer/Treatments and not “Non-OTC” products. NAD determined that “Non-OTC” may also be understood by consumers as a reference to prescription drug products instead of cosmetic products like CeraVe’s. Without a more accurate descriptor such as “non-prescription,” NAD concluded that there was a poor fit between the substantiation and the claim as it appears.

Nothing in NAD’s decision precludes L’Oréal from making truthful and non-misleading claims about dermatologists’ recommendations for its skincare products based on reliable survey data.

In its advertiser’s statement, L’Oréal stated that it will “appeal NAD’s decision that the underlying survey was not sufficiently reliable to support a ‘#1 Dermatologist Recommended Skincare Brand’ claim for the CeraVe brand without revised instructions.” L’Oréal further stated that it “will take NAD’s recommendations into account for future advertising” regarding the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.”

###

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.    

Blog

When Organizations Market To Children, They Should Do So Responsibly

Today's generation of digital natives might be more comfortable navigating gaming and content platforms, but they face the same cognitive limitations — and vulnerabilities — that children always have. The gap between a child’s needs online and the safeguards in place to protect them in digital spaces has grown to the point where big players like Google and Facebook are making more of an effort to address these gaps.
Read more
Blog

What Is Arbitration and What Should You Expect from It?

Arbitration is a form of dispute resolution and is an alternative to litigation (going to court). In some cases, a process called mediation will precede arbitration. In fact, more than 60% of claims that come through AUTO LINE are resolved in mediation. But, if a dispute cannot be resolved in mediation, the claim will proceed to arbitration.
Read more
Blog

The Potential Cost of Misleading Income Claims

The FTC recently put direct sellers, and other companies offering money-making opportunities, on notice: false promises about earnings potential and other aspects of a company’s business opportunity could subject the company to civil penalties. DSSRC published the Guidance on Earnings Claim for the Direct Selling Industry to reinforce fundamental tenets regarding the dissemination of earnings claims by direct selling companies and their independent salesforce members.
Read more
Blog

In-App and In-Game Ads: Tips to Staying Compliant in 2022

Today, children have increased access to technology as well as increased screen time, using apps and playing games, reading books, doing their homework, creatively expressing themselves, and socializing on their devices. As a result, business models have adapted, with apps reliant on ads and in-app purchases for revenue, rather than up-front purchase fees. These new business models require special design considerations outlined in CARU's revised Advertising Guidelines.
Read more

NAD Recommends L’Oréal Discontinue “#1 Dermatologist Recommended” Claim for CeraVe; Advertiser to Appeal

For Immediate Release
Contact: Abby Hills, Director of Communications, BBB National Programs

703.247.9330 / press@bbbnp.org

New York, NY – January 28, 2021 – The National Advertising Division (NAD) of BBB National Programs recommended that L’Oréal USA, Inc. discontinue claims that CeraVe is the “#1 dermatologist recommended skincare brand” and that it is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

The claims at issue, which appeared in online advertising, social media, and on in-store materials for CeraVe skincare products, were challenged by Johnson & Johnson Consumer Inc., the maker of competing Neutrogena brand facial and body cleansers, moisturizers, and sunscreens.

In support of its claim that CeraVe is the “#1 dermatologist recommended skincare brand,” L’Oréal relied on data from an online survey of approximately 1,500 dermatologists, which recorded the number and percentage of dermatologists’ average weekly recommendations by brand name in the surveyed categories. For certain conditions like acne, the survey asks about brand recommendations in multiple product categories, for example, “Acne: Cleansers” and “Acne: Moisturizers/Treatments.” Certain survey categories are identified by particular skin conditions like “Eczema.” Other survey categories call for brand recommendations in a particular product category, which in some instances is tied directly to a specific condition (e.g., “Wart Remover”) and in other instances is not directly tied to a particular condition (e.g., “Male Oriented Skin Care Products”).

L’Oréal relied on the results from 33 of the 48 categories in the survey, which it considered relevant to consumers’ understanding of “skincare,” and omitted those for which dermatologists did not report any recommendations in the 12 months ending December 2019, March 2020, or May 2020, and those it deemed irrelevant to the common conception of “skincare.”

After evaluating the methodology of the survey, although NAD did not take issue with its general methodology or with the particular categories surveyed, NAD determined that it was not reliable because it did not adequately instruct respondents not to duplicate their total average weekly recommendations between and among categories and, therefore, created the possibility of double-counting or that dermatologists would record the same brand recommendation in different categories if the recommendation for a particular indication is applicable in multiple categories. 

NAD further concluded that in the absence of more explicit instructions, the potential for double counting is increased due to the format of the survey and its degree of inherent imprecision. For these reasons, NAD recommended that L’Oréal discontinue the claim that CeraVe is the “#1 dermatologist recommended skincare brand.”

NAD also recommended that L’Oréal discontinue the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.” 

NAD noted that while L’Oréal’s use of the term “non-OTC” is an effort to accurately distinguish its products from acne drug products sold without a prescription, the claim is based on survey data which called for dermatologists’ Average Weekly Recommendations for “OTC” Acne Moisturizer/Treatments and not “Non-OTC” products. NAD determined that “Non-OTC” may also be understood by consumers as a reference to prescription drug products instead of cosmetic products like CeraVe’s. Without a more accurate descriptor such as “non-prescription,” NAD concluded that there was a poor fit between the substantiation and the claim as it appears.

Nothing in NAD’s decision precludes L’Oréal from making truthful and non-misleading claims about dermatologists’ recommendations for its skincare products based on reliable survey data.

In its advertiser’s statement, L’Oréal stated that it will “appeal NAD’s decision that the underlying survey was not sufficiently reliable to support a ‘#1 Dermatologist Recommended Skincare Brand’ claim for the CeraVe brand without revised instructions.” L’Oréal further stated that it “will take NAD’s recommendations into account for future advertising” regarding the claim that CeraVe is the “#1 recommended non-OTC moisturizer for acne-prone skin.”

###

About BBB National Programs: BBB National Programs is where businesses turn to enhance consumer trust and consumers are heard. The non-profit organization creates a fairer playing field for businesses and a better experience for consumers through the development and delivery of effective third-party accountability and dispute resolution programs. Embracing its role as an independent organization since the restructuring of the Council of Better Business Bureaus in June 2019, BBB National Programs today oversees more than a dozen leading national industry self-regulation programs, and continues to evolve its work and grow its impact by providing business guidance and fostering best practices in arenas such as advertising, child-directed marketing, and privacy. To learn more, visit bbbprograms.org.

About the National Advertising Division: The National Advertising Division (NAD), a division of BBB National Programs, provides independent self-regulation and dispute resolution services, guiding the truthfulness of advertising across the U.S. NAD reviews national advertising in all media and its decisions set consistent standards for advertising truth and accuracy, delivering meaningful protection to consumers and leveling the playing field for business.    

 

 

Media Inquiry